Point of Care Evaluation of Fibrinolysis in Sepsis

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 22, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

August 31, 2025

Conditions
Fibrinolytic DefectSepsisCritical Illness
Interventions
DIAGNOSTIC_TEST

Clot Pro

This study enrolls patients admitted to the Adult ICU of Milan Policlinico Hospital with a diagnosis of sepsis or septic shock. A ClotPro® TPA test is performed at admission and on day 1, 2, 3, and 7. Specific markers of coagulation (PAI-1, Plasminogen, Protein C and S) and inflammation (Il-1beta, IL-6, IL-8, TNF-alpha, ADM) are tested at enrollment. Routine laboratory tests are performed daily. Hemorrhagic and thrombotic events are searched. The study ends at 28 days or upon ICU discharge.

Trial Locations (1)

20100

RECRUITING

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan

All Listed Sponsors
lead

Policlinico Hospital

OTHER